Sign in

    Xuesong Wang

    Vice President and Equity Research Analyst at Morgan Stanley

    Xuesong Wang is a Vice President and Equity Research Analyst at Morgan Stanley, specializing in the coverage of the telecommunications and media sectors with a focus on major Chinese companies such as China Mobile, China Unicom, and China Telecom. Known for her analytically rigorous approach, Wang has consistently provided top-tier research with strong performance metrics, achieving a success rate often exceeding 65% and generating robust returns as tracked by investor platforms. She began her career with Morgan Stanley in 2014 after completing internships at both KPMG and the Bank of China, and has since built a reputation for her deep sector expertise and impactful stock recommendations. Wang holds FINRA Series 7 and Series 63 licenses and is recognized for her insightful market commentary and accurate, actionable equity insights.

    Xuesong Wang's questions to TransMedics Group (TMDX) leadership

    Xuesong Wang's questions to TransMedics Group (TMDX) leadership • Q1 2025

    Question

    Xuesong Wang asked about the durability of OCS and NOP pricing, especially considering potential new competitors and a cost-sensitive CMS environment.

    Answer

    Executive Waleed Hassanein reframed the issue from price to value, arguing that OCS delivers unparalleled clinical and economic benefits to the entire transplant ecosystem. He asserted that competitors offering simple price discounts lack a comparable value proposition, especially if their technology still requires hours of cold storage. He expressed confidence that both CMS and commercial payers will continue to reimburse OCS because of the significant cost efficiencies and superior outcomes it provides.

    Ask Fintool Equity Research AI

    Xuesong Wang's questions to Sonendo (SONX) leadership

    Xuesong Wang's questions to Sonendo (SONX) leadership • Q3 2023

    Question

    Asked for details on the recent reduction in force and its impact on growth, as well as the pricing strategy for 2024 and any customer pushback on recent price increases.

    Answer

    The workforce reduction will not impact growth or customers, as it stems from completed projects and efficiency gains. The company will continue to focus on commercial execution and key initiatives. While not providing 2024 pricing guidance, they acknowledged some pushback from the lowest volume tier and are working to help those customers realize the full value of the system.

    Ask Fintool Equity Research AI